Prime-boost immunotherapy (Barinthus Biotherapeutics)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Prime-boost immunotherapy (Barinthus Biotherapeutics), covering 2025-11-10 to 2025-11-10. Get the full timeline:
Most recent: Clinical Trial Update: Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer [Phase 1, Phase 2]